Risk and course of COVID-19 in patients with Parkinson’s disease

Amantadine has begun to be used as a possible alternative in therapy to mitigate its effects. There is anecdotal evidence that patients with Parkinson's disease (PD) treated with amantadine and who test positive for COVID-19 often do not develop clinical manifestations of COVID-19. Objective: to compare the clinical course of COVID-19 in patients with PD who took or did not take amantadine sulfate. Patients and methods. A prospective continuous study included 142 patients with PD who were treated in Republican Clinical Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy in Kazan from October 2021 to January 2022. Patients filled out a proprietary internally developed questionnaire.

show abstract

A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study

Zalyalova

Мунасипова

Khasanova

et al. 2022

RJTAO

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Risk and course of COVID-19 in patients with Parkinson’s disease

Cited by 1 publication

References 41 publications

A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study

A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study

Contact Info

Product

Resources

About